Latham & Watkins advised the lead investor on its Series C investment in Oviva, a health tech startup. Oviva’s US$80 million Series C funding brings its total raised to date to US$115 million.
Oviva combines expert advice from dietitians with digital tools to help people with conditions such as type 2 diabetes improve their health. Oviva will use the new capital to scale up its business.
The Latham team was led by London partner Mike Turner and associate Samantha Si.
LEGAL DESIRE NEWSLETTER
Where the legal industry reads first.
Enjoyed this article? Get the biggest legal industry updates, deals, appointments, insights and expert interviews in your inbox, free.
No spam. Unsubscribe anytime.